Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

PJ Online | News: Scottish control of entry rules may differ after OFT

Home > PJ (current issue) > News / Daily News | Search

Return to PJ Online Home Page

The Pharmaceutical Journal
Vol 269 No 7226 p769
30 November 2002

This article
Reprint
Photocopy


News summary

Related websites
Scottish Pharmaceutical General Council (www.spgc.org.uk)


Scottish control of entry rules may differ after OFT

Rules governing the control of entry to pharmaceutical contracts in Scotland may differ from those in England and Wales after the Office of Fair Trading makes its report, bodies representing pharmacy contractors in Scotland believe.

Bob Cuddihy, Scottish public affairs executive for the Scottish Pharmaceutical Federation, told The Journal that the OFT report will be studied by Scottish Health Ministers after its publication. They will then decided whether to amend the NHS (Pharmaceutical Services) (Scotland) Regulations 1995. Mr Cuddihy commented: ?I would be surprised if the OFT's proposals are implemented in Scotland if they do not fit in with the Scottish health plan." The SPF and the Scottish Pharmaceutical General Council recently sent a joint briefing to Members of the Scottish Parliament on the background to the OFT inquiry and its possible effects.

The two bodies say that the current regulations should be retained in order to maintain the National Health Service's community pharmacy network. They says that removing control of entry could mean that health boards are no longer able to plan and manage the number of dispensing pharmacies in their areas. They add: "The 'patient interest' is different to the 'consumer interest' or the 'public interest' because patients are often less mobile and value local, convenient services."

A spokeswoman for the OFT said that the pharmacy report is still expected to be published before the end of the year.

Back to Top

Home | Journals | News | Notice-board | Search | Jobs  Classifieds | Site Map | Contact us

©The Pharmaceutical Journal

Citation: The Pharmaceutical Journal URI: 20008294

Rate this article 

Click to rate

  • 1 star out of 5
  • 2 stars out of 5
  • 3 stars out of 5
  • 4 stars out of 5
  • 5 stars out of 5

0 out of 5 stars

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete
  • Print
  • Share
  • Comment
  • Rate
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.